glycine has been researched along with Obesity in 98 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The metabolic signature associated with obesity is characterized by a decrease in plasma glycine concentration, a feature closely associated with insulin resistance and highly predictive of the risk of developing chronic metabolic diseases." | 9.41 | Alterations in glycine metabolism in obesity and chronic metabolic diseases - an update on new advances. ( Alves, A; Morio, B, 2023) |
| "Glycine supplementation improves various components of metabolic syndrome including diabetes, obesity, hyperlipidemia and hypertension." | 9.22 | Effects of glycine on metabolic syndrome components: a review. ( Hossenzadeh, H; Imenshahidi, M, 2022) |
| "To investigate the effect of obesity on the pharmacokinetics and pharmacodynamics of melagatran after oral administration of ximelagatran." | 9.10 | No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran. ( Eriksson, UG; Homolka, R; Peters, GR; Sarich, TC; Svensson, M; Teng, R; Wollbratt, M, 2003) |
| " In addition, the plasma level of glycine is decreased in obesity, and the decrease is strongly correlated with the severity of insulin resistance." | 8.12 | Glycine Supplementation in Obesity Worsens Glucose Intolerance through Enhanced Liver Gluconeogenesis. ( Alves, A; Bassot, A; Bloise, AMNLG; Chanon, S; Drevet Mulard, E; Godet, M; Lamarche, F; Lefebvre, R; Loizon, E; Morio, B; Panthu, B; Pinteur, C; Rautureau, GJP, 2022) |
| "Obesity is associated with altered glycine metabolism in humans." | 7.96 | Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats. ( Edwards, AK; McKnight, SM; Satterfield, MC; Simmons, RM; Wu, G, 2020) |
| "Glycine (Gly) lowers hypercholesterolemia, hypertriglyceridemia and hypertension but its role in preventing adipocyte hypertrophy and modulating enzymatic activity of adipocytes has not been studied." | 7.83 | Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model. ( Castro, ES; Díaz-Díaz, E; Espejel, RV; Lans, VG; López, YR; Pérez-Torres, I; Zúñiga-Muñoz, A, 2016) |
| " The subjects carrying Gly16 or Glu27 alleles regardless of BMI had greater total fat mass, W/H and plasma leptin compared with those without the Gly16 or Glu27 alleles, indicating that Gly16 and Glu27 alleles of the beta2-adrenoceptor gene are related to obesity and fat mass." | 7.73 | Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. ( Fu, Y; Katsuya, T; Kawaguchi, H; Masuo, K; Ogihara, T; Rakugi, H; Tuck, ML, 2006) |
| "Glycine (Gly) has been reported to enhance the expression of tight-junction proteins in porcine enterocytes." | 5.62 | Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity. ( Chen, J; Dai, Z; Kim, IH; Wu, G; Wu, Z; Yang, Y, 2021) |
| "Obesity was found to be associated with decreased vessel H2S concentration, inward hypertrophic remodeling, altered collagen-to-elastin ratio, and reduced vessel stiffness." | 5.43 | Hydrogen sulfide depletion contributes to microvascular remodeling in obesity. ( Candela, J; Velmurugan, GV; White, C, 2016) |
| "The metabolic signature associated with obesity is characterized by a decrease in plasma glycine concentration, a feature closely associated with insulin resistance and highly predictive of the risk of developing chronic metabolic diseases." | 5.41 | Alterations in glycine metabolism in obesity and chronic metabolic diseases - an update on new advances. ( Alves, A; Morio, B, 2023) |
| "Obesity is associated with insulin resistance and other major cardiovascular risk factors." | 5.30 | Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. ( Breban, D; Hell, E; Krempler, F; Patsch, W; Winkler, C, 1998) |
| "Glycine supplementation improves various components of metabolic syndrome including diabetes, obesity, hyperlipidemia and hypertension." | 5.22 | Effects of glycine on metabolic syndrome components: a review. ( Hossenzadeh, H; Imenshahidi, M, 2022) |
| " Furthermore, glycine could be linked to metabolic health and insulin sensitivity through the betaine osmolyte." | 5.22 | Network Analysis of Metabolite GWAS Hits: Implication of CPS1 and the Urea Cycle in Weight Maintenance. ( Astrup, A; Carayol, J; Charon, C; Fazelzadeh, P; Hager, J; Lefebvre, G; Matone, A; Morine, M; Saris, WH; Scott-Boyer, MP; Valsesia, A; Vervoort, J, 2016) |
| "To investigate the effect of obesity on the pharmacokinetics and pharmacodynamics of melagatran after oral administration of ximelagatran." | 5.10 | No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran. ( Eriksson, UG; Homolka, R; Peters, GR; Sarich, TC; Svensson, M; Teng, R; Wollbratt, M, 2003) |
| "Humans are exposed to obesity causing Bisphenol A in various ways, especially through diet and food containers." | 4.31 | Exposure to environmental pollutant bisphenol A causes oxidative damage and lipid accumulation in Zebrafish larvae: Protective role of WL15 peptide derived from cysteine and glycine-rich protein 2. ( Arockiaraj, J; Guru, A, 2023) |
| " Glycine-β-muricholic acid (Gly-MCA) is an intestine-specific FXR antagonist previously shown to have favorable metabolic effects on obesity and insulin resistance." | 4.12 | Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice. ( Amin, SG; Desai, D; Gao, X; Gonzalez, FJ; Jiang, J; Krausz, KW; Liu, Y; Lu, D; Ma, Y; Patterson, AD; Xie, C, 2022) |
| " In addition, the plasma level of glycine is decreased in obesity, and the decrease is strongly correlated with the severity of insulin resistance." | 4.12 | Glycine Supplementation in Obesity Worsens Glucose Intolerance through Enhanced Liver Gluconeogenesis. ( Alves, A; Bassot, A; Bloise, AMNLG; Chanon, S; Drevet Mulard, E; Godet, M; Lamarche, F; Lefebvre, R; Loizon, E; Morio, B; Panthu, B; Pinteur, C; Rautureau, GJP, 2022) |
| "Obesity is associated with altered glycine metabolism in humans." | 3.96 | Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats. ( Edwards, AK; McKnight, SM; Satterfield, MC; Simmons, RM; Wu, G, 2020) |
| "Glycine (Gly) lowers hypercholesterolemia, hypertriglyceridemia and hypertension but its role in preventing adipocyte hypertrophy and modulating enzymatic activity of adipocytes has not been studied." | 3.83 | Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model. ( Castro, ES; Díaz-Díaz, E; Espejel, RV; Lans, VG; López, YR; Pérez-Torres, I; Zúñiga-Muñoz, A, 2016) |
| " Since we demonstrated that glycine supplementation can reduce inflammation and muscle wasting, we hypothesized that glycine supplementation during CR would preserve muscle mass in mice." | 3.83 | Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice. ( Caldow, MK; Chee, A; Godeassi, DP; Ham, DJ; Koopman, R; Lynch, GS, 2016) |
| " Here we show that treatment of mice with glycine-β-muricholic acid (Gly-MCA) inhibits FXR signalling exclusively in intestine, and improves metabolic parameters in mouse models of obesity." | 3.81 | Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction. ( Amin, SG; Bisson, WH; Brocker, CN; Desai, D; Gavrilova, O; Gonzalez, FJ; Jiang, C; Krausz, KW; Li, J; Liu, Y; Lv, Y; Patterson, AD; Shi, J; Xie, C, 2015) |
| " In the present study the influence of a four-week daily oral administration of 2 mg/kg body weight ciprofibrate (CAS 52214-84-3) or of 100 mg/kg body weight clofibric acid (CAS 882-09-7) was compared to that of the respective doses of their newly synthesized glycine conjugates in adult male lean and obese Zucker rats." | 3.74 | Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats. ( Deufel, T; Fleck, C; Karge, E; Lupp, A; Oelschlägers, H, 2008) |
| " The subjects carrying Gly16 or Glu27 alleles regardless of BMI had greater total fat mass, W/H and plasma leptin compared with those without the Gly16 or Glu27 alleles, indicating that Gly16 and Glu27 alleles of the beta2-adrenoceptor gene are related to obesity and fat mass." | 3.73 | Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation. ( Fu, Y; Katsuya, T; Kawaguchi, H; Masuo, K; Ogihara, T; Rakugi, H; Tuck, ML, 2006) |
| "To determine whether there are variations in leptin levels according to the beta(3)-adrenoceptor (beta(3)-AR) Trp64Arg and uncoupling protein 1 (UCP1) -3826A-->G polymorphisms, given the regulatory role of catecholamines through the beta(3)-AR in leptin production and the previously reported association of the UCP1 -3826A-->G variant with obesity." | 3.72 | The Arg64 allele of the beta 3-adrenoceptor gene but not the -3826G allele of the uncoupling protein 1 gene is associated with increased leptin levels in the Spanish population. ( Fernández-Pérez, C; González-Sánchez, JL; Martínez-Larrad, MT; Palou, A; Proenza, AM; Ramis, JM; Serrano-Ríos, M, 2004) |
| "The effects of low energy diets on protein metabolism in terms of the metabolic pool, active protein pool, and active and inactive protein synthesis rates were studied using [15N]glycine in five obese patients (percentage of ideal body weight, 120-190%)." | 3.67 | Effects of low energy diets on protein metabolism studies with [15N]glycine in obese patients. ( Koh, H; Koishi, H; Kurata, M; Nambu, S; Oi, Y; Okuda, T; Waki, M, 1987) |
| "Using the glycine-l-14C-cholic acid (14C-GCA) test, bile salt deconjugation and excretion were studied in 26 subjects with morbid exogenous obesity before and at selected intervals after jejuno-ileal bypass." | 3.65 | Studies on bile salt deconjugation following small bowel bypass procedures. ( Margraf, H; Stein, T; Wise, L, 1975) |
| "Given the potential of boron in the treatment of obesity, the aim of this study is to investigate the anti-adipogenic activity of the newly synthesised boron glycine monoester compound (BGM) using 3T3-L1 adipocytes by analysing lipid accumulation, CTRP3 and PPARy gene expression, oxidative stress and apoptotic effects." | 1.72 | BGM, a Newly Synthesised Boron Compound, Induces Apoptosis and Reduces Oxidative Stress by Inhibiting Lipogenesis in 3T3-L1 Adipocytes via PPARγ and CTRP3. ( Koldemir Gündüz, M, 2022) |
| "Glycine (Gly) has been reported to enhance the expression of tight-junction proteins in porcine enterocytes." | 1.62 | Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity. ( Chen, J; Dai, Z; Kim, IH; Wu, G; Wu, Z; Yang, Y, 2021) |
| "Obesity was found to be associated with decreased vessel H2S concentration, inward hypertrophic remodeling, altered collagen-to-elastin ratio, and reduced vessel stiffness." | 1.43 | Hydrogen sulfide depletion contributes to microvascular remodeling in obesity. ( Candela, J; Velmurugan, GV; White, C, 2016) |
| " Moreover, chronic administration of JTT-551 showed an antiobesity effect and an improvement of glucose and lipid metabolism in DIO mice." | 1.40 | Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice. ( Fukuda, S; Ito, M; Morinaga, H; Ohta, T; Sakata, S, 2014) |
| "Obesity is widely recognized as cause of metabolic syndrome and cardiovascular disease." | 1.36 | Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2. ( Alarcon-Aguilar, FJ; Almanza-Perez, JC; Blancas-Flores, G; Campos-Sepulveda, AE; Cruz, M; Garcia-Macedo, R; Roman-Ramos, R, 2010) |
| "Hydrogen sulfide (H(2)S) has been traditionally known for its toxic effects on living organisms." | 1.35 | Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats. ( Cao, K; Duridanova, D; Jia, X; Wang, R; Wu, L; Yang, G; Yang, W, 2009) |
| "Obesity is commonly associated with a high incidence and prevalence of dyslipidaemia, cardiovascular disease and Type II diabetes." | 1.31 | The effect of rate of weight loss on erythrocyte glutathione concentration and synthesis in healthy obese men. ( Calder, AG; Duthie, GG; Elia, M; Faber, P; Gibney, ER; Johnstone, AM; Lobley, GE; Stubbs, RJ, 2002) |
| "Obesity is associated with insulin resistance and other major cardiovascular risk factors." | 1.30 | Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. ( Breban, D; Hell, E; Krempler, F; Patsch, W; Winkler, C, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (26.53) | 18.7374 |
| 1990's | 5 (5.10) | 18.2507 |
| 2000's | 26 (26.53) | 29.6817 |
| 2010's | 28 (28.57) | 24.3611 |
| 2020's | 13 (13.27) | 2.80 |
| Authors | Studies |
|---|---|
| Imenshahidi, M | 1 |
| Hossenzadeh, H | 1 |
| Ye, Z | 1 |
| Zhang, C | 1 |
| Wang, S | 1 |
| Zhang, Y | 1 |
| Li, R | 1 |
| Zhao, Y | 1 |
| Qiao, J | 1 |
| Koldemir Gündüz, M | 1 |
| Guru, A | 1 |
| Arockiaraj, J | 1 |
| Jiang, J | 1 |
| Ma, Y | 1 |
| Liu, Y | 2 |
| Lu, D | 1 |
| Gao, X | 1 |
| Krausz, KW | 2 |
| Desai, D | 2 |
| Amin, SG | 2 |
| Patterson, AD | 2 |
| Gonzalez, FJ | 2 |
| Xie, C | 2 |
| Alves, A | 3 |
| Morio, B | 3 |
| Lamarche, F | 1 |
| Lefebvre, R | 1 |
| Drevet Mulard, E | 1 |
| Bassot, A | 2 |
| Chanon, S | 1 |
| Loizon, E | 1 |
| Pinteur, C | 1 |
| Bloise, AMNLG | 1 |
| Godet, M | 1 |
| Rautureau, GJP | 1 |
| Panthu, B | 1 |
| Hay, RE | 1 |
| Edwards, A | 1 |
| Klein, M | 1 |
| Hyland, L | 1 |
| MacDonald, D | 1 |
| Karatsoreos, I | 1 |
| Hill, MN | 1 |
| Abizaid, A | 1 |
| Simmons, RM | 1 |
| McKnight, SM | 1 |
| Edwards, AK | 1 |
| Wu, G | 2 |
| Satterfield, MC | 1 |
| White, PJ | 1 |
| Lapworth, AL | 1 |
| McGarrah, RW | 1 |
| Kwee, LC | 1 |
| Crown, SB | 1 |
| Ilkayeva, O | 1 |
| An, J | 1 |
| Carson, MW | 1 |
| Christopher, BA | 1 |
| Ball, JR | 1 |
| Davies, MN | 1 |
| Kjalarsdottir, L | 1 |
| George, T | 1 |
| Muehlbauer, MJ | 1 |
| Bain, JR | 1 |
| Stevens, RD | 1 |
| Koves, TR | 1 |
| Muoio, DM | 1 |
| Brozinick, JT | 1 |
| Gimeno, RE | 1 |
| Brosnan, MJ | 1 |
| Rolph, TP | 1 |
| Kraus, WE | 1 |
| Shah, SH | 1 |
| Newgard, CB | 1 |
| Camacho-Barcia, L | 1 |
| García-Gavilán, J | 1 |
| Papandreou, C | 1 |
| Hansen, TT | 1 |
| Harrold, JA | 1 |
| Finlayson, G | 1 |
| Blundell, JE | 1 |
| Sjödin, A | 1 |
| Halford, JCG | 1 |
| Bulló, M | 1 |
| Boutin, JA | 1 |
| Jullian, M | 1 |
| Frankiewicz, L | 1 |
| Galibert, M | 1 |
| Gloanec, P | 1 |
| Le Diguarher, T | 1 |
| Dupuis, P | 1 |
| Ko, A | 1 |
| Ripoll, L | 1 |
| Bertrand, M | 1 |
| Pecquery, A | 1 |
| Ferry, G | 1 |
| Puget, K | 1 |
| Chen, J | 1 |
| Yang, Y | 2 |
| Dai, Z | 1 |
| Kim, IH | 1 |
| Wu, Z | 1 |
| Orellana, ER | 1 |
| Jamis, C | 1 |
| Horvath, N | 1 |
| Hajnal, A | 1 |
| Vandenbeek, R | 1 |
| Khan, NP | 1 |
| Estall, JL | 1 |
| Margolis, LM | 1 |
| Ceglia, L | 1 |
| Rivas, DA | 1 |
| Dawson-Hughes, B | 1 |
| Fielding, RA | 1 |
| Khukhlina, O | 1 |
| Antoniv, A | 1 |
| Kanovska, L | 1 |
| Mandryk, O | 1 |
| Smandych, V | 1 |
| Zheng, JQ | 1 |
| Zhang, GR | 1 |
| Li, J | 2 |
| Bi, HW | 1 |
| Bulteau, AL | 1 |
| Pirola, L | 1 |
| Haviland, JA | 1 |
| Reiland, H | 1 |
| Butz, DE | 1 |
| Tonelli, M | 1 |
| Porter, WP | 1 |
| Zucchi, R | 1 |
| Scanlan, TS | 1 |
| Chiellini, G | 1 |
| Assadi-Porter, FM | 1 |
| Geng, B | 1 |
| Cai, B | 1 |
| Liao, F | 1 |
| Zheng, Y | 1 |
| Zeng, Q | 1 |
| Fan, X | 1 |
| Gong, Y | 1 |
| Yang, J | 1 |
| Cui, QH | 1 |
| Tang, C | 1 |
| Xu, GH | 1 |
| Linder, DE | 1 |
| Freeman, LM | 1 |
| Holden, SL | 1 |
| Biourge, V | 1 |
| German, AJ | 1 |
| Sato, S | 1 |
| Sakurai, T | 1 |
| Ogasawara, J | 1 |
| Takahashi, M | 1 |
| Izawa, T | 1 |
| Imaizumi, K | 1 |
| Taniguchi, N | 1 |
| Ohno, H | 1 |
| Kizaki, T | 1 |
| Jamroz-Wiśniewska, A | 1 |
| Gertler, A | 1 |
| Solomon, G | 1 |
| Wood, ME | 1 |
| Whiteman, M | 1 |
| Bełtowski, J | 1 |
| Tastesen, HS | 1 |
| Keenan, AH | 1 |
| Madsen, L | 1 |
| Kristiansen, K | 1 |
| Liaset, B | 1 |
| Ito, M | 1 |
| Fukuda, S | 1 |
| Sakata, S | 1 |
| Morinaga, H | 1 |
| Ohta, T | 1 |
| McMurray, F | 1 |
| Demetriades, M | 1 |
| Aik, W | 1 |
| Merkestein, M | 1 |
| Kramer, H | 1 |
| Andrew, DS | 1 |
| Scudamore, CL | 1 |
| Hough, TA | 1 |
| Wells, S | 1 |
| Ashcroft, FM | 1 |
| McDonough, MA | 1 |
| Schofield, CJ | 1 |
| Cox, RD | 1 |
| Caldow, MK | 1 |
| Ham, DJ | 1 |
| Godeassi, DP | 1 |
| Chee, A | 1 |
| Lynch, GS | 1 |
| Koopman, R | 1 |
| Jiang, C | 1 |
| Lv, Y | 1 |
| Shi, J | 1 |
| Brocker, CN | 1 |
| Bisson, WH | 1 |
| Gavrilova, O | 1 |
| Schmid, A | 1 |
| Neumann, H | 1 |
| Karrasch, T | 1 |
| Liebisch, G | 1 |
| Schäffler, A | 1 |
| Matone, A | 1 |
| Scott-Boyer, MP | 1 |
| Carayol, J | 1 |
| Fazelzadeh, P | 1 |
| Lefebvre, G | 1 |
| Valsesia, A | 1 |
| Charon, C | 1 |
| Vervoort, J | 1 |
| Astrup, A | 1 |
| Saris, WH | 1 |
| Morine, M | 1 |
| Hager, J | 1 |
| Candela, J | 1 |
| Velmurugan, GV | 1 |
| White, C | 1 |
| López, YR | 1 |
| Pérez-Torres, I | 1 |
| Zúñiga-Muñoz, A | 1 |
| Lans, VG | 1 |
| Díaz-Díaz, E | 1 |
| Castro, ES | 1 |
| Espejel, RV | 1 |
| Kim, YJ | 1 |
| Huh, I | 1 |
| Kim, JY | 1 |
| Park, S | 1 |
| Ryu, SH | 1 |
| Kim, KB | 1 |
| Kim, S | 1 |
| Park, T | 2 |
| Kwon, O | 1 |
| Lupp, A | 1 |
| Karge, E | 1 |
| Deufel, T | 1 |
| Oelschlägers, H | 1 |
| Fleck, C | 1 |
| Alarcon-Aguilar, FJ | 2 |
| Almanza-Perez, J | 1 |
| Blancas, G | 1 |
| Angeles, S | 1 |
| Garcia-Macedo, R | 2 |
| Roman, R | 1 |
| Cruz, M | 2 |
| Wu, L | 1 |
| Yang, W | 1 |
| Jia, X | 1 |
| Yang, G | 1 |
| Duridanova, D | 1 |
| Cao, K | 1 |
| Wang, R | 1 |
| Ouederni, TB | 1 |
| Sanchez-Corona, J | 1 |
| Flores Martinez, SE | 1 |
| Ben Maiz, H | 1 |
| Skhiri, HA | 1 |
| Abid, HK | 1 |
| Benammar-Elgaaied, A | 1 |
| Kim, SH | 1 |
| Yang, SO | 1 |
| Kim, HS | 1 |
| Kim, Y | 1 |
| Choi, HK | 1 |
| Almanza-Perez, JC | 1 |
| Blancas-Flores, G | 1 |
| Campos-Sepulveda, AE | 1 |
| Roman-Ramos, R | 1 |
| Maarman, G | 1 |
| Marais, E | 1 |
| Lochner, A | 1 |
| du Toit, EF | 1 |
| Beadle, RM | 1 |
| Yue, JT | 1 |
| Mighiu, PI | 1 |
| Naples, M | 1 |
| Adeli, K | 1 |
| Lam, TK | 1 |
| Mencarelli, M | 1 |
| Zulian, A | 1 |
| Cancello, R | 1 |
| Alberti, L | 1 |
| Gilardini, L | 1 |
| Di Blasio, AM | 1 |
| Invitti, C | 1 |
| Keung, W | 1 |
| Ussher, JR | 1 |
| Jaswal, JS | 1 |
| Raubenheimer, M | 1 |
| Lam, VH | 1 |
| Wagg, CS | 1 |
| Lopaschuk, GD | 1 |
| Lees, HJ | 1 |
| Swann, JR | 1 |
| Wilson, ID | 1 |
| Nicholson, JK | 1 |
| Holmes, E | 1 |
| Muller, YL | 1 |
| Bogardus, C | 2 |
| Pedersen, O | 1 |
| Baier, L | 1 |
| Sarich, TC | 1 |
| Teng, R | 1 |
| Peters, GR | 1 |
| Wollbratt, M | 1 |
| Homolka, R | 1 |
| Svensson, M | 1 |
| Eriksson, UG | 1 |
| Stefan, N | 1 |
| Kovacs, P | 1 |
| Stumvoll, M | 1 |
| Hanson, RL | 1 |
| Lehn-Stefan, A | 1 |
| Permana, PA | 1 |
| Baier, LJ | 1 |
| Tataranni, PA | 1 |
| Silver, K | 1 |
| Jellema, A | 1 |
| Zeegers, MP | 1 |
| Feskens, EJ | 1 |
| Dagnelie, PC | 1 |
| Mensink, RP | 1 |
| HUGHES, AM | 1 |
| TOLBERT, BM | 1 |
| CRISTOFORI, FC | 1 |
| DUNCAN, GG | 1 |
| D'Adamo, M | 1 |
| Perego, L | 1 |
| Cardellini, M | 1 |
| Marini, MA | 1 |
| Frontoni, S | 1 |
| Andreozzi, F | 1 |
| Sciacqua, A | 1 |
| Lauro, D | 1 |
| Sbraccia, P | 1 |
| Federici, M | 1 |
| Paganelli, M | 1 |
| Pontiroli, AE | 1 |
| Lauro, R | 1 |
| Perticone, F | 1 |
| Folli, F | 1 |
| Sesti, G | 1 |
| Ramis, JM | 1 |
| González-Sánchez, JL | 1 |
| Proenza, AM | 1 |
| Martínez-Larrad, MT | 1 |
| Fernández-Pérez, C | 1 |
| Palou, A | 1 |
| Serrano-Ríos, M | 1 |
| Nakashima, T | 1 |
| Sumida, Y | 1 |
| Mitsuyoshi, H | 1 |
| Okanoue, T | 1 |
| Bidzińska, B | 1 |
| Demissie, M | 1 |
| Tworowska, U | 1 |
| Slezak, R | 1 |
| Dobosz, T | 1 |
| Milewicz, A | 1 |
| Harrity, T | 1 |
| Farrelly, D | 1 |
| Tieman, A | 1 |
| Chu, C | 1 |
| Kunselman, L | 1 |
| Gu, L | 1 |
| Ponticiello, R | 1 |
| Cap, M | 1 |
| Qu, F | 1 |
| Shao, C | 1 |
| Wang, W | 1 |
| Zhang, H | 1 |
| Fenderson, W | 1 |
| Chen, S | 1 |
| Devasthale, P | 1 |
| Jeon, Y | 1 |
| Seethala, R | 1 |
| Yang, WP | 1 |
| Ren, J | 1 |
| Zhou, M | 1 |
| Ryono, D | 1 |
| Biller, S | 1 |
| Mookhtiar, KA | 1 |
| Wetterau, J | 1 |
| Gregg, R | 1 |
| Cheng, PT | 1 |
| Hariharan, N | 1 |
| Fanelli, M | 1 |
| Filippi, E | 1 |
| Sentinelli, F | 1 |
| Romeo, S | 1 |
| Fallarino, M | 1 |
| Buzzetti, R | 1 |
| Leonetti, F | 1 |
| Baroni, MG | 1 |
| Ridderstråle, M | 1 |
| Johansson, LE | 1 |
| Rastam, L | 1 |
| Lindblad, U | 1 |
| Pyrzak, B | 1 |
| Wiśniewska, A | 1 |
| Rymkiewicz-Kluczyńska, B | 1 |
| Masuo, K | 1 |
| Katsuya, T | 1 |
| Kawaguchi, H | 1 |
| Fu, Y | 1 |
| Rakugi, H | 1 |
| Ogihara, T | 1 |
| Tuck, ML | 1 |
| Mo, W | 1 |
| Zhang, GG | 1 |
| Yang, TL | 1 |
| Dai, XP | 1 |
| Li, HH | 1 |
| Zeng, H | 1 |
| Liu, J | 1 |
| Tan, YM | 1 |
| Zhou, HH | 1 |
| Liu, ZQ | 1 |
| Peeters, A | 1 |
| Beckers, S | 1 |
| Mertens, I | 1 |
| Van Hul, W | 1 |
| Van Gaal, L | 1 |
| Gougeon, R | 2 |
| Morais, JA | 2 |
| Chevalier, S | 1 |
| Pereira, S | 1 |
| Lamarche, M | 1 |
| Marliss, EB | 2 |
| von Studnitz, W | 1 |
| Krag, E | 2 |
| Højgaard, L | 1 |
| Garlick, PJ | 1 |
| Clugston, GA | 1 |
| Waterlow, JC | 2 |
| Winterer, J | 1 |
| Bistrian, BR | 1 |
| Bilmazes, C | 1 |
| Blackburn, GL | 1 |
| Young, VR | 1 |
| Ivy, JL | 1 |
| Cortez, MY | 1 |
| Chandler, RM | 1 |
| Byrne, HK | 1 |
| Miller, RH | 1 |
| Jones, PJ | 1 |
| Pencharz, PB | 1 |
| Krempler, F | 1 |
| Hell, E | 1 |
| Winkler, C | 1 |
| Breban, D | 1 |
| Patsch, W | 1 |
| Ebbeling, CB | 1 |
| Rodriguez, NR | 1 |
| Mori, Y | 1 |
| Kim-Motoyama, H | 1 |
| Ito, Y | 1 |
| Katakura, T | 1 |
| Yasuda, K | 1 |
| Ishiyama-Shigemoto, S | 1 |
| Yamada, K | 1 |
| Akanuma, Y | 1 |
| Ohashi, Y | 1 |
| Kimura, S | 1 |
| Yazaki, Y | 1 |
| Kadowaki, T | 1 |
| Meirhaeghe, A | 1 |
| Helbecque, N | 1 |
| Cottel, D | 1 |
| Amouyel, P | 1 |
| Hayakawa, T | 1 |
| Nagai, Y | 1 |
| Kahara, T | 1 |
| Yamashita, H | 1 |
| Takamura, T | 1 |
| Abe, T | 1 |
| Nomura, G | 1 |
| Kobayashi, K | 1 |
| Marchini, JS | 1 |
| Lambertini, CR | 1 |
| Ferriolli, E | 1 |
| Dutra de Oliveira, JE | 1 |
| Faber, P | 1 |
| Johnstone, AM | 1 |
| Gibney, ER | 1 |
| Elia, M | 1 |
| Stubbs, RJ | 1 |
| Duthie, GG | 1 |
| Calder, AG | 1 |
| Lobley, GE | 1 |
| Dionne, IJ | 1 |
| Garant, MJ | 1 |
| Nolan, AA | 1 |
| Pollin, TI | 1 |
| Lewis, DG | 1 |
| Shuldiner, AR | 1 |
| Poehlman, ET | 1 |
| Wise, L | 3 |
| Stein, T | 3 |
| Golden, MH | 1 |
| Ell, MS | 1 |
| Bruusgaard, A | 1 |
| Sörensen, TI | 1 |
| Justesen, T | 2 |
| Müller, WA | 1 |
| Aoki, TT | 1 |
| Cahill, GF | 2 |
| Margraf, H | 1 |
| Oi, Y | 2 |
| Okuda, T | 2 |
| Miyoshi, H | 1 |
| Koishi, H | 2 |
| Koh, H | 1 |
| Waki, M | 1 |
| Kurata, M | 1 |
| Nambu, S | 1 |
| Danö, P | 2 |
| Lenz, K | 2 |
| Sherr, HP | 1 |
| Nair, PP | 1 |
| White, JJ | 2 |
| Banwell, JG | 1 |
| Lockwood, DH | 2 |
| Halliday, D | 1 |
| Garrow, JS | 1 |
| Rodgers, PA | 1 |
| Sehlin, J | 1 |
| Gylfe, E | 1 |
| Moxley, RT | 1 |
| Pozefsky, T | 1 |
| Deleña, S | 1 |
| Brown, H | 1 |
| Adibi, SA | 1 |
| Felig, P | 1 |
| Marliss, E | 1 |
| Mandell, AJ | 1 |
| Rubin, RT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Controlled and Randomized Clinical Trial for Evaluating the Effect of a Supplement of Glycine as Adjuvant in the Treatment of COVID-19 Pneumonia in Patients Initiating Mechanical Ventilation[NCT04443673] | 59 participants (Actual) | Interventional | 2020-06-15 | Terminated (stopped due to An interim analysis showed no difference in major outcomes (n=35 glycine and n=24 control participants)) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for glycine and Obesity
| Article | Year |
|---|---|
Effects of glycine on metabolic syndrome components: a review.
Topics: Exercise; Glycine; Humans; Life Style; Metabolic Syndrome; Obesity | 2022 |
Alterations in glycine metabolism in obesity and chronic metabolic diseases - an update on new advances.
Topics: Amino Acids, Branched-Chain; Diet; Glycine; Humans; Insulin Resistance; Metabolic Diseases; Obesity | 2023 |
Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism.
Topics: Amino Acid Substitution; Diabetes Mellitus, Type 2; Genetic Linkage; Genetic Predisposition to Disea | 2018 |
Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases.
Topics: Biological Availability; Diabetes Mellitus, Type 2; Diet; Gastrointestinal Microbiome; Glycine; Huma | 2019 |
Hippurate: the natural history of a mammalian-microbial cometabolite.
Topics: Age Factors; Animals; Atherosclerosis; Autistic Disorder; Benzoic Acid; Diabetes Mellitus; Diet; Fem | 2013 |
Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies.
Topics: Amino Acid Substitution; Arginine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Genetic Carrier Scr | 2003 |
[Treatment of nonalcoholic steatohepatitis (NASH)].
Topics: Cysteine; Diet; Drug Combinations; Fatty Liver; Glycine; Hepatitis; Humans; Insulin Resistance; Live | 2004 |
Bile acid metabolism after intestinal bypass operations.
Topics: Bile; Bile Acids and Salts; Glycine; Humans; Ileum; Jejunum; Kinetics; Obesity; Taurine | 1981 |
Interactions between carbohydrate, protein, and fat metabolism in starvation.
Topics: Alanine; Amino Acids; Ammonia; Carbohydrate Metabolism; Gluconeogenesis; Glycerol; Glycine; Humans; | 1969 |
5 trials available for glycine and Obesity
| Article | Year |
|---|---|
Pilot Study Examining the Influence of Potassium Bicarbonate Supplementation on Nitrogen Balance and Whole-Body Ammonia and Urea Turnover Following Short-Term Energy Restriction in Older Men.
Topics: Aged; Ammonia; Bicarbonates; Body Mass Index; Diet, Reducing; Dietary Supplements; Energy Intake; Gl | 2018 |
Network Analysis of Metabolite GWAS Hits: Implication of CPS1 and the Urea Cycle in Weight Maintenance.
Topics: Adult; Ammonia; Betaine; Caloric Restriction; Carbamoyl-Phosphate Synthase (Ammonia); Carbamyl Phosp | 2016 |
Integration of Traditional and Metabolomics Biomarkers Identifies Prognostic Metabolites for Predicting Responsiveness to Nutritional Intervention against Oxidative Stress and Inflammation.
Topics: Adult; Biomarkers; Body Mass Index; Diet; Erythrocytes; Female; Glutathione; Glycine; Humans; Inflam | 2017 |
No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran.
Topics: Administration, Oral; Adult; Area Under Curve; Azetidines; Benzylamines; Female; Glycine; Half-Life; | 2003 |
Obese women on a low energy rice and bean diet: effects of leucine, arginine or glycine supplementation on protein turnover.
Topics: Adult; Amino Acids; Analysis of Variance; Arginine; Diet, Reducing; Dietary Proteins; Dietary Supple | 2001 |
84 other studies available for glycine and Obesity
| Article | Year |
|---|---|
Amino acid signatures in relation to polycystic ovary syndrome and increased risk of different metabolic disturbances.
Topics: Alanine; Amino Acids; Body Mass Index; Female; Glycine; Humans; Insulin Resistance; Lysine; Metaboli | 2022 |
BGM, a Newly Synthesised Boron Compound, Induces Apoptosis and Reduces Oxidative Stress by Inhibiting Lipogenesis in 3T3-L1 Adipocytes via PPARγ and CTRP3.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Alprostadil; Animals; Annexin A5; Antioxidants; Apoptosis; B | 2022 |
Exposure to environmental pollutant bisphenol A causes oxidative damage and lipid accumulation in Zebrafish larvae: Protective role of WL15 peptide derived from cysteine and glycine-rich protein 2.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Cysteine; Glutathione; Glycine; Humans; Larva; Obesity; | 2023 |
Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice.
Topics: Animals; Ceramides; Glycine; Intestines; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Receptors | 2022 |
Glycine Supplementation in Obesity Worsens Glucose Intolerance through Enhanced Liver Gluconeogenesis.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Gluconeogenesis; Glucose Intolerance; Glycine; Insulin | 2022 |
Ghrelin Receptor Signaling Is Not Required for Glucocorticoid-Induced Obesity in Male Mice.
Topics: Adiposity; Animals; Eating; Glucocorticoids; Glycine; Hippocampus; Male; Mice; Mice, Inbred C57BL; M | 2020 |
Obesity increases hepatic glycine dehydrogenase and aminomethyltransferase expression while dietary glycine supplementation reduces white adipose tissue in Zucker diabetic fatty rats.
Topics: Adipose Tissue, White; Alanine; Aminomethyltransferase; Animals; Appetite Regulation; Body Weight; D | 2020 |
Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion.
Topics: Amino Acids, Branched-Chain; Animals; Glycine; Liver; Male; Muscle, Skeletal; Nitrogen; Obesity; Rat | 2020 |
Circulating Metabolites Associated with Postprandial Satiety in Overweight/Obese Participants: The SATIN Study.
Topics: Adult; Aged; Appetite Regulation; Area Under Curve; Cross-Sectional Studies; Double-Blind Method; Fa | 2021 |
MCH-R1 Antagonist GPS18169, a Pseudopeptide, Is a Peripheral Anti-Obesity Agent in Mice.
Topics: Adipose Tissue; Alkynes; Aminobutyrates; Animals; Anti-Obesity Agents; Appetite; Aspartic Acid; Dise | 2021 |
Dietary Supplementation with Glycine Enhances Intestinal Mucosal Integrity and Ameliorates Inflammation in C57BL/6J Mice with High-Fat Diet-Induced Obesity.
Topics: Animals; Diet, High-Fat; Dietary Supplements; Gastrointestinal Microbiome; Glycine; Inflammation; Ma | 2021 |
Effect of vertical sleeve gastrectomy on alcohol consumption and preferences in dietary obese rats and mice: A plausible role for altered ghrelin signaling.
Topics: Alcohol Drinking; Analysis of Variance; Animals; Blood Glucose; Central Nervous System Depressants; | 2018 |
EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE.
Topics: Administration, Oral; Anti-Inflammatory Agents; Cysteine; Drug Administration Schedule; Drug Combina | 2018 |
Neutrophil elastase inhibitor suppresses oxidative stress in obese asthmatic rats by activating Keap1/Nrf2 signaling pathway.
Topics: Animals; Antioxidants; Asthma; Disease Models, Animal; Glycine; Humans; Kelch-Like ECH-Associated Pr | 2019 |
NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment.
Topics: 3-Hydroxybutyric Acid; Animals; Body Weight; Breath Tests; Dietary Proteins; Dose-Response Relations | 2013 |
Increase or decrease hydrogen sulfide exert opposite lipolysis, but reduce global insulin resistance in high fatty diet induced obese mice.
Topics: Adipocytes; Alkynes; Animals; Blood Glucose; Carrier Proteins; Cystathionine gamma-Lyase; Cysteine; | 2013 |
Status of selected nutrients in obese dogs undergoing caloric restriction.
Topics: Amino Acids; Animals; Caloric Restriction; Choline; Creatinine; Dog Diseases; Dogs; Female; Glycine; | 2013 |
A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression.
Topics: Age Factors; Animals; Cell Adhesion; Cell Line; Cell Movement; Chemokine CCL2; Circadian Clocks; Gen | 2014 |
Leptin-induced endothelium-dependent vasorelaxation of peripheral arteries in lean and obese rats: role of nitric oxide and hydrogen sulfide.
Topics: Adipose Tissue; Alkynes; Animals; Biological Factors; Bismuth; Cystathionine gamma-Lyase; Diet; Endo | 2014 |
Scallop protein with endogenous high taurine and glycine content prevents high-fat, high-sucrose-induced obesity and improves plasma lipid profile in male C57BL/6J mice.
Topics: Adipose Tissue; Animals; Diet, High-Fat; Dietary Proteins; Energy Intake; Glycine; Lipids; Male; Mic | 2014 |
Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity mice.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glu | 2014 |
Pharmacological inhibition of FTO.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Anti-Obesity Agents; Cell Line; Drug Evaluat | 2015 |
Glycine supplementation during calorie restriction accelerates fat loss and protects against further muscle loss in obese mice.
Topics: Animals; Body Composition; Body Mass Index; Caloric Restriction; Cytokines; Diet, High-Fat; Dietary | 2016 |
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
Topics: Adolescent; Adult; Aged; Animals; Ceramides; Cholic Acids; Diet, High-Fat; Fatty Liver; Female; Glyc | 2015 |
Bile Acid Metabolome after an Oral Lipid Tolerance Test by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Topics: Adolescent; Adult; Anthropometry; Bile Acids and Salts; Chromatography, Liquid; Contraceptives, Oral | 2016 |
Hydrogen sulfide depletion contributes to microvascular remodeling in obesity.
Topics: Alkynes; Animals; Arterioles; Cells, Cultured; Collagen; Collagenases; Cystathionine gamma-Lyase; Di | 2016 |
Effect of Glycine on Adipocyte Hypertrophy in a Metabolic Syndrome Rat Model.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Pressure; Fatty Acids; Glycine; Hypertrophy; Insulin; Lip | 2016 |
Ciprofibrate, clofibric acid and respective glycinate derivatives. Effects of a four-week treatment on male lean and obese Zucker rats.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Clofibric Acid; Cytochrome P-450 Enzym | 2008 |
Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice.
Topics: 3T3 Cells; Adiponectin; Animals; Cytokines; Disease Models, Animal; Gene Expression Regulation; Gluc | 2008 |
Pancreatic islet overproduction of H2S and suppressed insulin release in Zucker diabetic rats.
Topics: Alkynes; Animals; Blood Glucose; Catalysis; Cystathionine gamma-Lyase; Diabetes Mellitus; Glycine; H | 2009 |
The G1057D polymorphism of IRS-2 gene is not associated with type 2 diabetes and obese patients among ethnic groups in Tunisian population.
Topics: Aspartic Acid; Black People; Diabetes Mellitus, Type 2; Ethnicity; Female; Genetic Predisposition to | 2009 |
1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet.
Topics: Acetoacetates; Acetone; Animals; Betaine; Citric Acid; Dietary Fats; Disease Models, Animal; Glycine | 2009 |
Glycine regulates inflammatory markers modifying the energetic balance through PPAR and UCP-2.
Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Energy Metabol | 2010 |
Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity.
Topics: Animals; Body Weight; Carnitine O-Palmitoyltransferase; Diet; Disease Models, Animal; Enzyme Inhibit | 2012 |
Reducing the burden of ischemia reperfusion: editorial to: "Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity" by G. Maarman et al.
Topics: Animals; Carnitine O-Palmitoyltransferase; Enzyme Inhibitors; Glycine; Male; Myocardial Infarction; | 2012 |
Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats.
Topics: Adiponectin; Animals; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Dietary Fats; Dyslipidemias; Fat | 2012 |
A novel missense mutation in the signal peptide of the human POMC gene: a possible additional link between early-onset type 2 diabetes and obesity.
Topics: Animals; Arginine; Cell Line, Tumor; Coronary Disease; Diabetes Mellitus, Type 2; Female; Genetic Lo | 2012 |
Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.
Topics: Animals; Anti-Obesity Agents; Carbohydrate Metabolism; Carnitine O-Palmitoyltransferase; Cell Membra | 2013 |
A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians.
Topics: Adipocytes; Adipose Tissue; Adult; Alleles; Blood Glucose; Body Composition; Body Mass Index; Cell S | 2003 |
Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
Topics: Adult; Amino Acid Substitution; Animals; Arizona; Aspartic Acid; Base Sequence; Body Composition; Co | 2003 |
Oxidation of acetate, glucose, or glycine to carbon dioxide in mice exhibiting the hereditary obesity syndrome.
Topics: Acetates; Animals; Carbohydrate Metabolism; Carbon Dioxide; Glucose; Glycine; Mice; Obesity; Oxidati | 1958 |
URIC ACID EXCRETION IN OBESE SUBJECTS DURING PERIODS OF TOTAL FASTING.
Topics: Acidosis; Basal Metabolism; Blood Glucose; Fasting; Glycine; Humans; Obesity; Pennsylvania; Probenec | 1964 |
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.
Topics: Adipose Tissue; Adult; Alanine; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Genotype; G | 2004 |
The Arg64 allele of the beta 3-adrenoceptor gene but not the -3826G allele of the uncoupling protein 1 gene is associated with increased leptin levels in the Spanish population.
Topics: Adipocytes; Adult; Alanine; Arginine; Blood Glucose; Body Mass Index; Carrier Proteins; Cholesterol; | 2004 |
[Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
Topics: Alanine; Body Mass Index; Case-Control Studies; Female; Gene Frequency; Glycine; Humans; Male; Obesi | 2004 |
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Topics: Adiponectin; Animals; Blood Glucose; Corticosterone; Diabetes Mellitus, Type 2; Diet; Female; Glycin | 2006 |
The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
Topics: Adult; Amino Acid Substitution; Female; Genetic Predisposition to Disease; Glucose Intolerance; Glyc | 2005 |
Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
Topics: Adult; Age Distribution; Aged; Alleles; Exercise; Female; Glycine; Heat-Shock Proteins; Humans; Leis | 2006 |
[The influence of polymorphism the Gly972Arg variant insulin receptor substrate-1 (IRS-1) gene, and G-308A TNF-alpha gene on obesity and insulin resistance in children with obesity].
Topics: Adolescent; Arginine; Child; Female; Gene Frequency; Glycine; Humans; Insulin Receptor Substrate Pro | 2006 |
Beta2-adrenoceptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic activation.
Topics: Adult; Alleles; Blood Pressure; Body Weight; Cohort Studies; Gene Expression Regulation; Gene Freque | 2006 |
The genetic polymorphisms of beta3-adrenergic receptor (AR) Trp64Arg and beta2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients.
Topics: Aged; Arginine; Base Sequence; DNA Primers; Glutamic Acid; Glycine; Humans; Hypertension; Male; Midd | 2007 |
The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men.
Topics: Abdominal Fat; Adiposity; Adult; Alanine; Case-Control Studies; Female; Glycine; Humans; Male; Middl | 2007 |
Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes.
Topics: Adult; Basal Metabolism; Body Weight; Diabetes Mellitus, Type 2; Female; Glycine; Humans; Kinetics; | 2008 |
Urinary excretion of aminoacetone following administration of L-threonine in man.
Topics: Amino Acids; Creatinine; Dietary Carbohydrates; Electrophoresis; Glycine; Humans; Ketone Bodies; Lev | 1967 |
Influence of low-energy diets on whole-body protein turnover in obese subjects.
Topics: Adult; Aged; Diet, Reducing; Dietary Proteins; Female; Glycine; Humans; Leucine; Male; Middle Aged; | 1980 |
Whole body protein turnover, studied with 15N-glycine, and muscle protein breakdown in mildly obese subjects during a protein-sparing diet and a brief total fast.
Topics: Adult; Dietary Proteins; Fasting; Female; Glycine; Humans; Kinetics; Methylhistidines; Muscle Protei | 1980 |
Effects of pyruvate on the metabolism and insulin resistance of obese Zucker rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Cholesterol; Energy Metabolism; Female; G | 1994 |
Effect of exogenous insulin on protein metabolism with differing nonprotein energy intakes in Type 2 diabetes mellitus.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Proteins; Energy Intake; | 1998 |
Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1.
Topics: Adult; Amino Acid Substitution; Arginine; Blood Glucose; Case-Control Studies; Codon; Female; Genoty | 1998 |
Effects of reduced energy intake on protein utilization in obese children.
Topics: Amino Acids; Basal Metabolism; Body Weight; Child; Creatinine; Diet; Energy Metabolism; Female; Glyc | 1998 |
The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men.
Topics: Adipose Tissue; Adult; Aged; Alleles; Blood Glucose; Blood Pressure; Gene Frequency; Glutamic Acid; | 1999 |
Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population.
Topics: Adult; Arginine; Body Constitution; Body Mass Index; Body Weight; Female; France; Genotype; Glutamic | 2000 |
Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene are not associated with obesity in Japanese men.
Topics: Adult; Aged; Arginine; Codon; Gene Frequency; Glutamic Acid; Glutamine; Glycine; Heterozygote; Homoz | 2000 |
The effect of rate of weight loss on erythrocyte glutathione concentration and synthesis in healthy obese men.
Topics: Amino Acids; Anthropometry; Body Composition; Erythrocytes; Glutathione; Glycine; Humans; Lipids; Ma | 2002 |
Association between obesity and a polymorphism in the beta(1)-adrenoceptor gene (Gly389Arg ADRB1) in Caucasian women.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Arginine; Body Mass Index; Body Weight; Energy Intake; Ener | 2002 |
The effect of jejunoileal bypass on bile composition and the formation of billiary calculi.
Topics: Adult; Bile; Cholelithiasis; Cholesterol; Follow-Up Studies; Glycine; Humans; Ileum; Jejunum; Micell | 1978 |
The use of urinary ammonia as end-product in measurements of total protein turnover with 15N.
Topics: Adult; Ammonia; Child; Glycine; Humans; Obesity; Proteins | 1977 |
Bile acid metabolism after jejunoileal bypass operation for obesity.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Duodenum; Glycine; Huma | 1976 |
Effect of alanine and glycine on glucagon secretion in postabsorptive and fasting obese man.
Topics: Adolescent; Adult; Alanine; Blood Glucose; Fasting; Female; Glucagon; Glycine; Humans; Insulin; Male | 1975 |
Studies on bile salt deconjugation following small bowel bypass procedures.
Topics: Bile Acids and Salts; Carbon Dioxide; Carbon Radioisotopes; Evaluation Studies as Topic; Feces; Glyc | 1975 |
Biliary and urinary calculi: pathogenesis following small bowel bypass for obesity.
Topics: Adult; Bile; Bile Acids and Salts; Calcium; Cholelithiasis; Follow-Up Studies; Glycine; Humans; Inte | 1975 |
Effects of restricted diet on protein metabolism measured by [15N]glycine in high-fat-diet-induced obese rats.
Topics: Animals; Caseins; Diet, Reducing; Dietary Fats; Dietary Proteins; Energy Intake; Glycine; Male; Nitr | 1987 |
Effects of low energy diets on protein metabolism studies with [15N]glycine in obese patients.
Topics: Body Weight; Diet, Reducing; Energy Metabolism; Female; Glycine; Humans; Kinetics; Male; Middle Aged | 1987 |
Bile acid metabolism and intestinal bacterial flora after three types of intestinal shunt operation for obesity.
Topics: Adolescent; Adult; Bile Acids and Salts; Carbon Radioisotopes; Enterobacteriaceae; Female; Glycine; | 1974 |
Bile acid metabolism and hepatic disease following small bowel bypass for obesity.
Topics: Adult; Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; | 1974 |
Proceedings: A simple technique for the estimation of tissue protein turnover in man.
Topics: Dietary Proteins; Energy Metabolism; Glycine; Humans; Nitrogen Isotopes; Obesity; Protein Biosynthes | 1974 |
Transport and oxidation of glycine in mammalian pancreatic islets with reference to the mechanism of amino acid-induced insulin release.
Topics: Amino Acids; Animals; Autoradiography; Carbon Dioxide; Carbon Isotopes; Glycine; Hyperglycemia; In V | 1972 |
Change of bile acid metabolism and absorption of vitamin B 12 after intestinal shunt operation in obesity. A comparison of three types of operation.
Topics: Adolescent; Adult; Bacteroides; Bile Acids and Salts; Breath Tests; Carbon Dioxide; Carbon Radioisot | 1974 |
Changes of free amino acids in pancreatic beta-cells after starvation and substrate deprivation.
Topics: Alanine; Amino Acids; Aminobutyrates; Animals; Aspartic Acid; Carbon Radioisotopes; Chromatography, | 1974 |
Transient kwaskiorkor: A cause of fatty liver following small bowel bypass.
Topics: Adult; Amino Acids; Body Weight; Dietary Carbohydrates; Dietary Proteins; Fatty Liver; Female; Glyci | 1974 |
Effect of glycine loading on Delta-Aminolevulinic acid (ALA) and porphobilinogen (PBG) excretion during starvation.
Topics: Adolescent; Adult; Amino Acids; Body Weight; Female; Glycine; Humans; Hydro-Lyases; Levulinic Acids; | 1969 |
Influence of dietary deprivations on plasma concentration of free amino acids of man.
Topics: Adolescent; Adult; Alanine; Amino Acids; Chromatography, Ion Exchange; Diet; Dietary Proteins; Femal | 1968 |
Plasma amino acid levels and insulin secretion in obesity.
Topics: Adolescent; Adult; Amino Acids; Blood Glucose; Fasting; Feedback; Female; Glucose; Glycine; Humans; | 1969 |
Indolylacroyl glycine excretion in man.
Topics: Acrylates; Chromatography, Paper; Glycine; Humans; In Vitro Techniques; Indoles; Infrared Rays; Ment | 1965 |